Respiratory Devices – Their evolution and history
Respiratory devices are those devices that are used for patients having respiratory diseases and these devices help in the removal of the mucus from the airways thereby improving the pulmonary functions of the patient suffering from respiratory disease. The history of respiratory therapy itself is quite ancient with the earliest beginning of the inhalation practice of medicine in the form of vapors, aromatherapy that dates back to around 6000 B.C. The respiratory therapy has its roots in Egypt, India, China and the Middle East.
Read full report info: http://www.marketdataforecast.com/market-reports/global-respiratory-devices-market-728/
The origins of respiratory devices date back to the time when Leonardo da Vinci recommended using wet cloth for the protection of inhaling gas/pollutants due to toxic powered weapons. In the modern era, Captain Stokes M.D. in 1917 used rubber nasal catheter and nasal prongs to administer oxygen for World War-I pulmonary edema patients and during the same year, H.E.G Boyle invented anesthesia devices that revolutionized the respiratory devices market.
Respiratory devices market – An eagle’s eye view-
The global respiratory care devices market was worth the US $14.44 billion in 2016. By 2021, it is estimated to reach the US $21.4 billion due to rising prevalence of respiratory disorders such as cardiopulmonary diseases and growing awareness of the people to access improved healthcare infrastructure. In addition, the technological and design innovations in respiratory care devices are expected to enhance the respiratory device market size. The growing geriatric population is also one of the major factors that are driving respiratory market size.
May i send you free sample report, Request here: http://www.marketdataforecast.com/market-reports/global-respiratory-devices-market-728/request-sample
As per the respiratory devices market report, the prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA) as types of respiratory illness has increased manifold due to environmental pollution across the globe. The rate of prevalence increased from 3.2% among the people in the age group of 18-44 years to more than 11.6% among those exceeding 65 years. COPD and tuberculosis together account for around 12.5 million deaths globally, which is around 1/5th of the worldwide total deaths. The respiratory devices are helping physicians in removing or eliminating mucus from the respiratory tract of the patients.
As such, there emerged the necessity of proper medical intervention that leads to the demand for anesthesia and respiratory devices both as home care products as well as for hospitals that require oxygen therapy among patients.
Respiratory monitoring devices market – What is in store?
The respiratory monitoring devices are those devices that are used for patient monitoring taking into account the patient parameters such as heartbeat, blood pressure, heart rate and rhythm, respiratory rate, blood-oxygen saturation and other parameters. Devices used for such parameter measurements are called as patient monitoring devices. The global respiratory therapy market is segmented based on Type, Therapeutic Devices, Disposables and End Users. Each of these segments is further sub-divided as shown in the tabulated format for the ease of reading.
|Therapeutic Devices||Diagnostic and Monitoring Devices||Disposables||End Users|
|BI-PAP Devises||Sleep Test Devices||Cannulas||Hospitals|
|Nebulizers||Pulse Oximeter||Filters||Home Care|
|Resuscitators||Peak Flow Meters||Tubes|
|CPAP Devises||Capnographs||Breathing Circuits|
Figure: 1 – Market Segmentation of respiratory monitoring devices
The global respiratory monitoring devices market is set to accelerate due to patient friendly, cost effective and portable products that are now available in the market is further encouraging the usage of these devices. In terms of geography or regional wise segmentation of respiratory monitoring devices – North America tops the chart followed by Europe and Asia- Pacific regions.
During 2016, the therapeutic devices segment occupied the largest share of the global respiratory care devices market. The North American therapeutic devices market share in terms of respiratory device market size was worth over the US $3 billion in 2015 with the U.S. therapeutic respiratory devices market contributing to more than half of the North American revenue.
The key players or companies’ active in the global respiratory care devices market includes the following ones-
- GE Healthcare
- Philips Healthcare
- Covidien Plc
- Care Fusion Corporation
- Siemens Healthcare
The global respiratory market is highly competitive with the key players involving themselves in the development of unique and innovative devices. These companies adopt development strategies to expand their market in developing economies such as India, Brazil through acquisitions and agreements to increase their respiratory device market share.